Summary: Hepatic angiomyolipoma was considered to be a rare benign tumor, but the number of cases has been increasing recently as imaging techniques improve. We describe a case of hepatic angiomyolipoma for which a definitive diagnosis could not be made on imagings and in which resection was performed. The patient had anti-HCV antibody and slight dysfunction of the liver . The tumor showed a heterogeneous high echo on ultrasonography and a low attenuation value of + 32.6 Housfield Units, which was much higher than fat density, on plain computed tomography . Discrimination from hepatocellular carcinoma with fatty change was difficult preoperatively . Microscopically, the tumor consisted of spindle-shaped and epithelioid smooth muscles, adipose tissues and proliferating blood vessels and these histological findings confirmed the diagnosis of hepatic angiomyolipoma.
The appearance of hepatic angiomyolipoma on imaging diagnosis varies widely due to the fact that the relative proportion of vessels, muscles and fats varies widely from tumor to tumor. The tumor in our case had relatively few fat components.
We review 48 cases reported in Japan and discuss imaging diagnosis and surgical indications for tumors.
INTRODUCTION
Angiomyolipoma (AML) is usually seen in the kidney associated with tuberous sclerosis. Hepatic AML used to be a rare benign tumor, first described by Isahak in 1976 [1] . However, with recent progress in imaging diagnostic techniques, cases of hepatic AML are increasing in number [2] [3] [4] and the significance of accurate diagnosis is becoming more important clinically. Sometimes, it is difficult to make a definitive diagnosis of hepatic AML, and it is especially difficult to distinguish hepatic AML from hepatocellular carcinoma with fatty change on imagings [5] [6] [7] . We report a case of resected hepatic AML, discuss difficulties in imaging diagnosis before surgery, and we review the literature in Japan.
CASE REPORT
A 59-year-old man was found to have a tumor in segment VI of the liver by abdominal ultrasonography (US) at a medical check up in July 1996. He had no symptoms related to the hepatic tumor and no family history of tuberous sclerosis. He was referred to our hospital for further examination and treatment for hepatic tumor on September 10, 1996. Liver, spleen and tumor were not palpable at physical examination on admission. The laboratory data showed a slightly disturbed liver function with chronic hepatitis: GOT 72U/L, GPT 116U/L, gamma-GTP 87U/L, Indocyanin green retention test 22.7% and positive anti-HCV antibody. The serum levels of alpha-fetoprotein and des-gamma carboxy prothrombin were normal, but Carbohydrate antigen 19-9 (CA19-9) was slightly elevated at 43.0 U/ml.
US showed a high echoic mass measuring 4 cm in diameter that was a heterogeneous high echo in segment VI of the liver ( Fig. 1-a) . Computed tomography (CT) showed a low attenuation mass with well-defined margins which was associated with the SAJIMA ET AL.
vascular structures, and the tumor showed arterioportal (A-P) shunt. The attenuation value of the tumor was +32.6 Hounsfield Unit (HU). In the magnetic resonance images (MRI), the T-1 weighted images of the tumor showed hypo intensity lesion and the T-2 weighted images showed hyper intensity lesion ( Fig. 1-b, c) . In the arterial phase of the right hepatic arteriography, the tumor showed hypervascularity and in the venous phase tumor stain was found ( Fig. 1-d (Fig. 2-a) . Pathological findings of resected specimen show three components of smooth muscle, adipose tissues and blood vessels in the tumor (Fig. 2-b) . Epithelioid tumor cells showed positive immunostaining for HMB-45, which is observed predominantly in the central of the cytoplasm. These histological findings confirmed the diagnosis of hepatic AML. 
DISCUSSION
One hundred and three cases of hepatic AML have been reported throughout the world to date. However, we seem to be encountering such cases more frequently in practice. In our review of 48 Japanese cases [2-17,19-21], the mean age was 49.9 (range: 27 to 76 year), and no sexual difference was reported. The average tumor size at detection was 6.9 cm (range: 0.6 to 36 cm). In half of the cases, the patients had no symptoms and the tumors were detected incidentally by medical check up. Patients with large tumors over 5 cm had usually some symptoms caused by tumor oDDression ( Table 1) .
The typical findings on imagings of hepatic AML are follows; 1) homogeneous hyper echo on US, 2) homogeneous low density with a low attenuation value (less than -20 HU) on plain CT, 3) high intensity on T1 and T2 weighted MRI, 4) hypervascularity and tumor stain on angiography (Table 2 ). However, hepatic AML sometimes shows various patterns on imagings. On US, hepatic AML generally shows hyper echo, but some are homogeneous and some are heterogeneous. On plain CT, tumors are detected as low density masses, but there is wide variation in the attenuation values. The differences on imagings occur because the relative proportions of vessels, muscles and fats vary widely from tumor to tumor. Consequently, hepatic AML is sometimes difficult to diagnose based on imagings. In the 48 reported cases, only 5 cases were diagnosed by imagings [8] [9] [10] [11] . Kawarada et al. [8] indicated that homogeneous . It is likely that contact inhibition works in benign tumors when the tumor do not enlarge. To elucidate these questions, further examinations will be required. We now propose the indication for resection as follows; absolute indication: 1) cases in whom diagnostic imaging and biopsy cannot make a definitive diagnosis of hepatic AML, 2) cases having some symptoms caused by tumor oppression, relative indication, 3) cases in whom the tumor shows extrahepatic growth and exhibits a risk of rupture, 4) cases in which the tumor shows a tendency to grow. In cases where the tumor has a risk of rupture or a tendency to grow, we should be circumspect about performing resection. However, consideration should be paid in non-resected follow-up cases to the malignant potential of the tumor. There are some reports describing malignant change of AML of the kidney [24], although no malignancy has found in hepatic AML.
